Reacción #1069757

ord-6476f3cbeb6643959e1a404384a9d32c

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroTwo granules are prepared
  2. 2
    Otrothe granules obtained
  3. 3
    Otroare then dried
  4. 4
    workup.ADDITIONThe other components, magnesium stearate, Aerosile® 200 and monosodium carbonate are then dry-added
  5. 5
    workup.ADDITIONmixed
  6. 6
    workup.ADDITIONFor granule 2, tiapride hydrochloride, Methocel® and Avicel® are dry-mixed
  7. 7
    Otrothe granules obtained
  8. 8
    Otroare then dried
  9. 9
    workup.ADDITIONMagnesium stearate and Aerosile® are dry-added
  10. 10
    workup.ADDITIONmixed
  11. 11
    Otro3-layer tablets are prepared
  12. 12
    workup.ADDITIONcontaining 250 mg of granule 1 in the first outer layer, 280 mg of granule 2 in the inner layer, which

Procedimiento

Two granules are prepared. For granule 1, Methocel® K100M, Avicel® PH102 and tartaric acid are dry-mixed and then granulated with water in a granulating blender and the granules obtained are then dried. The other components, magnesium stearate, Aerosile® 200 and monosodium carbonate are then dry-added and mixed. For granule 2, tiapride hydrochloride, Methocel® and Avicel® are dry-mixed and are then granulated with water in a granulating blender and the granules obtained are then dried. Magnesium stearate and Aerosile® are dry-added and mixed. 3-layer tablets are prepared, containing 250 mg of granule 1 in the first outer layer, 280 mg of granule 2 in the inner layer, which contains 100 mg of base tiapride in hydrochloride form, and 200 mg of granule 1 in the second outer layer.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US06861072B1uspto-grants-2005_03